Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Serve and enjoy
If IGF-1 has not risen 15 to 25% above baseline after 12 weeks of proper dosing and bedtime administration, discuss dose adjustment with your prescribing clinician
Its pharmacological signature potent GHS-R1a-mediated GH release with negligible off-target stimulation of cortisol, prolactin, or ACTH at research-relevant concentrations makes it the ghrelin receptor agonist of choice for investigators requiring isolated GHS-pathway activation without confounding neuroendocrine variables
By using a combined approach of Microarray-Bioinformatic technologies, the authors have revealed the overexpression of CPT1B in clinical tissue specimens of colorectal cancer, demonstrating a potential metabolic mechanism contributing to colorectal cancer
Another observation from studies on murine models exposed to catabolic agents revealed a reduction in the excretion of N-methylhistidine, a marker of muscle protein degradation, which was notably more pronounced with IGF-1 LR3potentially three times greater than with IGF-I
Immunity, atherosclerosis and cardiovascular disease
US$ 28.42
US$ 21.74
US$ 24.06
US$ 23.69
US$ 22.90
US$ 28.84
US$ 24.54
